Polycaprolactone coated hydroxyapatite microsphere material and preparation method thereof
The hydrophilic modified polycaprolactone polymer coats hydroxyapatite to form chemical bonded microspheres, which solves the problem of uneven dispersion of hydroxyapatite microspheres and improves its stability and biocompatibility , meets the application needs of beauty materials.
Patent Information
- Application Number
- CN202411006816.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Single hydroxyapatite materials are prone to agglomeration when used in microspheres, resulting in uneven dispersion and cannot meet complex application needs.
Hydrophilic modified polycaprolactone polymer is used to coat hydroxyapatite, and polycaprolactone-covered microspheres are formed through chemical bonding to improve its uniform dispersion stability.
The uniform dispersion stability of hydroxyapatite microsphere materials is achieved, which meets the application needs as injection cosmetic materials, and retains the biocompatibility of the materials.
Smart Images

Figure CN118949125A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of medical cosmetic materials, and specifically, to a polycaprolactone-coated hydroxyapatite microsphere material and a preparation method thereof. Background Art
[0002] Hydroxyapatite (HA), also known as artificial bone or bone powder, has a crystal structure and physical and chemical properties similar to the inorganic salt structure of human bone tissue. It has excellent biocompatibility and can be safely metabolized by the human body. Compared with traditional collagen and hyaluronic acid fillers, hydroxyapatite has a longer lasting effect. Based on the above excellent material properties, hydroxyapatite materials are widely used in the global medical beauty market and have become one of the fastest growing injectable beauty materials in recent years.
[0003] However, a single hydroxyapatite material often cannot meet complex application requirements. Due to the properties of hydroxyapatite itself, it is easy to agglomerate when used as microspheres, resulting in uneven dispersion. Summary of the invention
[0004] The purpose of the embodiments of the present application is to provide a polycaprolactone-coated hydroxyapatite microsphere material and a preparation method thereof. The material has good uniform dispersion stability and can meet practical application requirements.
[0005] In the first aspect, an embodiment of the present application provides a polycaprolactone-coated hydroxyapatite microsphere material, which includes a substrate and a coating layer wrapped around the surface of the substrate, the substrate contains hydroxyapatite, the coating layer contains a hydrophilically modified polycaprolactone polymer, and the substrate and the coating layer are connected by a chemical bond.
[0006] In the above technical solution, the hydrophilic modified polycaprolactone polymer is hydrophilic, and the polymer is wrapped on hydroxyapatite to form hydrophilic microspheres, which retains the characteristics of hydroxyapatite while improving the uniform dispersion stability of hydroxyapatite. Therefore, the material of the embodiment of the present application has good uniform dispersion stability and can meet the actual application needs.
[0007] In a possible implementation, the hydrophilically modified polycaprolactone polymer includes a copolymer of polycaprolactone and a hydrophilically modified compound, and the hydrophilically modified compound includes at least one of methylated polyethylene glycol, polyacrylic acid, amino acid, and ethanolamine.
[0008] In the above technical solution, the composition of the polycaprolactone coated hydroxyapatite microsphere material includes hydroxyapatite with a copolymer of polycaprolactone and a hydrophilic modified compound coated on the surface, and all components have good biocompatibility. The polycaprolactone in the coating layer is modified by the hydrophilic modified compound, and the obtained copolymer has hydrophilicity.
[0009] In a possible implementation, the particle size of the matrix is 20-100 μm.
[0010] In the above technical solution, the above matrix can be used to form microsphere materials with uniform sizes, thereby meeting the application requirements as injectable cosmetic materials.
[0011] In the second aspect, an embodiment of the present application provides a method for preparing the polycaprolactone-coated hydroxyapatite microsphere material of the aforementioned embodiment, wherein hydroxyapatite is reacted with ε-caprolactone and a hydrophilic modified compound to cause the ε-caprolactone to undergo ring-opening polymerization and copolymerize with the hydrophilic modified compound on the surface of the hydroxyapatite.
[0012] In the above technical scheme, ε-caprolactone undergoes ring-opening polymerization to form polycaprolactone, and the two ends of the polycaprolactone are modified by hydrophilic modified compounds and hydroxyapatite. The obtained microsphere material retains the characteristics of hydroxyapatite while being hydrophilic, not easy to agglomerate, and has strong practicality. The method is simple and convenient to operate.
[0013] In a possible implementation, the mass ratio of the hydroxyapatite to the ε-caprolactone and the hydrophilic modification compound is 15-30:40-60:1-15.
[0014] In a possible implementation, the reaction temperature is 100-200°C, and the reaction time is 1-24h;
[0015] And / or, continuous ultrasound and stirring during the reaction.
[0016] In the above technical solution, continuous ultrasound and stirring during the reaction can reduce the problem of hydroxyapatite agglomeration and improve the uniformity of the size of the product material.
[0017] In a possible implementation, the following steps are included:
[0018] uniformly dispersing hydroxyapatite in a solvent to form a hydroxyapatite solution;
[0019] The hydroxyapatite solution is mixed with ε-caprolactone and methylated polyethylene glycol, and reacted under the catalytic action of a catalyst and the protection of an inert gas;
[0020] The solid matter produced by the reaction is collected, washed and dried.
[0021] In the above technical scheme, ε-caprolactone undergoes ring-opening polymerization under the catalysis of the catalyst, and due to the adsorption of hydroxyapatite and Ca 2+ Due to the complexing property of polycaprolactone and polyethylene glycol, copolymerization occurs on the surface of hydroxyapatite to obtain hydroxyapatite microspheres wrapped by methylated polyethylene glycol-polycaprolactone block copolymer.
[0022] In a possible implementation, the dispersion method includes homogenization and ultrasonic treatment, the homogenization speed is 1000-10000 rap / min, the ultrasonic frequency is 30-80 KHZ, and the homogenization and ultrasonic time is 1-30 min.
[0023] In a possible implementation, the cleaning method includes: first rinsing with acetic acid or citric acid solution, and then rinsing with deionized water.
[0024] In the above technical solution, it is simple to remove the residue.
[0025] In a possible implementation, the catalyst includes at least one of stannous octoate, tetraphenyltin, Lewis acid, Schiff base, and organic carboxylic acid;
[0026] The drying method includes freeze drying. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments of the present application will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.
[0028] Figure 1 is the hydrogen spectrum of the hydroxyapatite microsphere material of Example 1;
[0029] Figure 2 This is the infrared spectrum of the hydroxyapatite microsphere material of Example 1. DETAILED DESCRIPTION
[0030] With the advancement of technology, more and more materials are used in surgical treatment.
[0031] Among them, hydroxyapatite (HA), also known as artificial bone or bone powder, has a crystal structure and physical and chemical properties similar to the inorganic salt structure of human bone tissue, has excellent biocompatibility, and can be safely metabolized by the human body. Compared with traditional collagen and hyaluronic acid fillers, the effect lasts longer. Based on this excellent material property, hydroxyapatite material is widely used in the global medical beauty market and has become one of the fastest growing injectable beauty materials in recent years.
[0032] In addition, polycaprolactone (PCL) is a thermoplastic crystalline polyester with many remarkable properties. First, PCL has excellent biodegradability and can be completely degraded within 6-12 months under natural conditions. Secondly, the biocompatibility and non-toxicity of PCL make it widely used in the medical field, such as surgical sutures, tissue engineering scaffolds, and drug sustained-release capsules.
[0033] However, single polycaprolactone or hydroxyapatite materials often cannot meet complex application requirements. Due to its properties, hydroxyapatite is prone to agglomeration when used as microspheres, resulting in uneven dispersion; polycaprolactone has strong hydrophobicity, which limits its wide application in biology.
[0034] Therefore, the present application proposes a hydrophilic coated composite material in which hydroxyapatite is coated with a copolymer of polycaprolactone and methylated polyethylene glycol, and the uniform dispersion stability is improved by coating the hydroxyapatite.
[0035] In order to make the purpose, technical scheme and advantages of the embodiments of the present application clearer, the technical scheme in the embodiments of the present application will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to the conventional conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.
[0036] The polycaprolactone-coated hydroxyapatite microsphere material and the preparation method thereof according to the embodiment of the present application are described in detail below.
[0037] The embodiment of the present application provides a polycaprolactone-coated hydroxyapatite microsphere material, which includes a substrate and a coating layer wrapped around the surface of the substrate, the substrate contains hydroxyapatite, the coating layer contains a hydrophilically modified polycaprolactone polymer, and the substrate and the coating layer are connected by chemical bonds.
[0038] In some embodiments of the present application, the hydrophilically modified polycaprolactone polymer includes a copolymer of polycaprolactone and a hydrophilically modified compound, and the hydrophilically modified compound includes at least one of methylated polyethylene glycol, polyacrylic acid, amino acid, and ethanolamine. Exemplarily, the hydrophilically modified polycaprolactone polymer is a copolymer of polycaprolactone and methylated polyethylene glycol. Methylated polyethylene glycol modification can increase the water solubility of polycaprolactone, so that the originally difficult to dissolve polycaprolactone can be better dissolved and dispersed; at the same time, the stability of polycaprolactone is increased and the degradation time is prolonged.
[0039] In some embodiments of the present application, the particle size of the matrix is 20-100 μm; the particle size of the corresponding polycaprolactone-coated hydroxyapatite microsphere material is 25-200 μm. Exemplarily, the average particle size of the matrix is 20 μm, 40 μm, 60 μm, 80 μm, 100 μm, or any intermediate value between the above two values.
[0040] In addition, an embodiment of the present application provides a method for preparing the polycaprolactone-coated hydroxyapatite microsphere material of the aforementioned embodiment, which mainly comprises reacting hydroxyapatite with ε-caprolactone and a hydrophilic modified compound to cause the ε-caprolactone to undergo ring-opening polymerization and copolymerize with the hydrophilic modified compound on the surface of hydroxyapatite.
[0041] In some embodiments of the present application, the mass ratio of hydroxyapatite to ε-caprolactone and hydrophilic modification compound is 15-30: 40-60: 1-15. Exemplarily, the mass ratio of hydroxyapatite to ε-caprolactone and hydrophilic modification compound is 20:50:2, 20:50:15 or other ratios.
[0042] In some embodiments of the present application, the reaction temperature is 100-200° C., and the reaction time is 1-24 h; ultrasound and stirring are continued during the reaction.
[0043] As an embodiment, the preparation method of polycaprolactone-coated hydroxyapatite microsphere material comprises the following steps:
[0044] S1. Dispersing hydroxyapatite uniformly in a solvent to form a hydroxyapatite solution.
[0045] In some embodiments of the present application, the particle size of hydroxyapatite is 20-100 μm; the solvent includes at least one of toluene, benzene, tetrahydrofuran, dichloromethane, ethyl acetate, etc.
[0046] In some embodiments of the present application, the dispersion method includes homogenization and ultrasonic treatment, the homogenization speed is 1000-10000 rap / min, the ultrasonic frequency is 30-80KHZ, and the homogenization and ultrasonic time is 1-30min.
[0047] S2, mixing the hydroxyapatite solution, ε-caprolactone and methylated polyethylene glycol, and reacting them under the catalytic action of a catalyst and under the protection of an inert gas;
[0048] In some embodiments of the present application, the catalyst includes at least one of stannous octoate, tetraphenyltin, Lewis acid, Schiff base, and organic carboxylic acid, and the inert gas includes nitrogen.
[0049] S3. Collect the solid matter produced by the reaction, wash it and dry it.
[0050] In some embodiments of the present application, the cleaning method includes: first rinsing with acetic acid or citric acid solution, and then rinsing with deionized water.
[0051] In some embodiments of the present application, the drying method includes freeze drying.
[0052] The features and performance of the present application are further described in detail below in conjunction with the embodiments.
[0053] Example 1
[0054] This embodiment provides a hydroxyapatite microsphere material, and the preparation method thereof is as follows:
[0055] 1. Add 20g hydroxyapatite (hydroxyapatite particle size is within 100μm) into 100ml toluene solution, and disperse it evenly by high-speed homogenization shearing and ultrasound. The homogenization speed is 10000rap / min, the ultrasonic frequency is 30-80KHZ, and the homogenization and ultrasound time is 30min to obtain a toluene suspension of hydroxyapatite.
[0056] 2. Add 50g of ε-caprolactone and 2g of methylated polyethylene glycol to the above dispersed suspension and protect with nitrogen.
[0057] 3. Raise the temperature to 150°C and add 0.02 g of stannous octoate for reaction. The reaction needs to be continuously protected by nitrogen and the reaction time is 24 hours.
[0058] 4. Filter the product, discard the filtrate, collect the filter cake, first rinse with dichloromethane to verify whether the coating layer can be washed off, then rinse with 0.1% acetic acid solution for 1 min, and rinse with deionized water for 5 min.
[0059] 5. Crush the filter cake and freeze-dry it to obtain hydroxyapatite microsphere material.
[0060] Example 2
[0061] This embodiment provides a hydroxyapatite microsphere material, which differs from the preparation method of embodiment 1 in that polyacrylic acid is used instead of methylated polyethylene glycol.
[0062] Example 3
[0063] This embodiment provides a hydroxyapatite microsphere material, which is different from the preparation method of embodiment 1 in that the amount of methylated polyethylene glycol used is 15 g.
[0064] Example 4
[0065] This embodiment provides a hydroxyapatite microsphere material, which differs from the preparation method of embodiment 1 in that the reaction temperature is 200° C. and the reaction time is 24 h.
[0066] Test experiment
[0067] 1. The hydroxyapatite microsphere material of Example 1 was tested, specifically using NMR 400 (reagent: deuterated chloroform) to obtain a hydrogen spectrum of the material, such as Figure 1 As shown;
[0068] In addition, the hydroxyapatite microsphere material of Example 1 was tested, specifically using a Fourier infrared instrument to obtain an infrared spectrum of the material, such as Figure 2 shown.
[0069] pass Figure 1 and Figure 2 It can be seen that the hydrogen spectrum and infrared spectrum of hydroxyapatite microspheres have corresponding peaks, specifically: infrared 2940.9cm -1 and 2862.6cm -1 :-CH2-; 1722.3cm -1 :C=O;1237.5cm -1 and 1103.3cm -1 :COC. Therefore, H-NMR and infrared can prove that there are polycaprolactone and copolymer materials on the surface of hydroxyapatite.
[0070] In addition, the material generated by the reaction in Example 1 was first eluted with dichloromethane, and polycaprolactone could still be detected in the end, indicating that hydroxyapatite and polycaprolactone were firmly bonded, that is, the matrix and the copolymer coating layer of the material were chemically bonded, rather than simply physically coated. On the contrary, if the copolymer coating layer prepared was not chemically bonded to the matrix, the unbonded polycaprolactone would be dissolved and washed away by dichloromethane, and finally could not be detected.
[0071] 2. The hydroxyapatite microsphere material and hydroxyapatite of Example 1 were subjected to stability test, and the test process was: mechanical stirring at 300 rpm for 10 min; homogenization at 3000 rpm for 3 min; and then standing at 40°C.
[0072] The test results are shown in Table 1:
[0073] Table 1 Comparison of aqueous solution stability of different materials (40°C)
[0074] time Hydroxyapatite Example 1 0min Homogeneous suspension Homogeneous suspension 30min Aggregation and sedimentation Homogeneous suspension 1h Continue to sink Homogeneous suspension 2h Complete Settlement Homogeneous suspension 4h - Homogeneous suspension 8h - Aggregation and sedimentation 24h - Not completely settled
[0075] It can be seen from the results in Table 1 that the aqueous solution of hydroxyapatite material itself has poor stability, and aggregation and sedimentation occur in 30 minutes; the aqueous solution stability of hydroxyapatite microsphere material obtained by coating hydroxyapatite in a specific manner in Example 1 is significantly improved, and aggregation and sedimentation occur in 8 hours.
[0076] In summary, the polycaprolactone-coated hydroxyapatite microsphere material of the embodiment of the present application has good uniform dispersion stability and can meet the actual application requirements.
[0077] The above description is only an embodiment of the present application and is not intended to limit the scope of protection of the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the scope of protection of the present application.
Claims
1. A polycaprolactone-coated hydroxyapatite microsphere material, characterized in that: The invention comprises a substrate and a coating layer wrapped on the surface of the substrate, wherein the substrate comprises hydroxyapatite, the coating layer comprises a hydrophilic modified polycaprolactone polymer, and the substrate and the coating layer are connected via chemical bonds.
2. The polycaprolactone-coated hydroxyapatite microsphere material according to claim 1, characterized in that: The hydrophilically modified polycaprolactone polymer comprises a copolymer of polycaprolactone and a hydrophilically modified compound, wherein the hydrophilically modified compound comprises at least one of methylated polyethylene glycol, polyacrylic acid, amino acid, and ethanolamine.
3. The polycaprolactone-coated hydroxyapatite microsphere material according to claim 1, characterized in that: The particle size of the matrix is 20-100 μm.
4. A method for preparing the polycaprolactone-coated hydroxyapatite microsphere material as claimed in claim 1, characterized in that: The hydroxyapatite is reacted with ε-caprolactone and a hydrophilic modification compound, so that the ε-caprolactone undergoes ring-opening polymerization and copolymerizes with the hydrophilic modification compound on the surface of the hydroxyapatite.
5. The method for preparing the polycaprolactone-coated hydroxyapatite microsphere material according to claim 4, characterized in that: The mass ratio of the hydroxyapatite to the ε-caprolactone and the hydrophilic modified compound is 15-30:40-60:1-15.
6. The method for preparing the polycaprolactone-coated hydroxyapatite microsphere material according to claim 4, characterized in that: The reaction temperature is 100-200°C and the reaction time is 1-24h; And / or, continuous ultrasound and stirring during the reaction.
7. The method for preparing polycaprolactone-coated hydroxyapatite microsphere material according to claim 6, characterized in that: It includes the following steps: uniformly dispersing hydroxyapatite in a solvent to form a hydroxyapatite solution; The hydroxyapatite solution is mixed with ε-caprolactone and methylated polyethylene glycol, and reacted under the catalytic action of a catalyst and the protection of an inert gas; The solid matter produced by the reaction is collected, washed and dried.
8. The method for preparing polycaprolactone-coated hydroxyapatite microsphere material according to claim 7, characterized in that: The dispersion method includes homogenization and ultrasonic treatment, the homogenization speed is 1000-10000 rap / min, the ultrasonic frequency is 30-80KHZ, and the homogenization and ultrasonic time is 1-30min.
9. The method for preparing polycaprolactone-coated hydroxyapatite microsphere material according to claim 7, characterized in that: The cleaning method includes: first rinsing with acetic acid or citric acid solution, and then rinsing with deionized water.
10. The method for preparing polycaprolactone-coated hydroxyapatite microsphere material according to claim 7, characterized in that: The catalyst includes at least one of stannous octoate, tetraphenyltin, Lewis acid, Schiff base, and organic carboxylic acid; The drying method includes freeze drying.
Citation Information
Patent Citations
Polycaprolactone / nano-hydroxyapatite composite material and method for preparing same
CN109575249A
Hydroxyapatite / polycaprolactone / polyethylene glycol composite bone scaffold material
CN113262329A
Method for modifying surface of hydroxyapatite nano-crystal
KR1020080069799A
Polycaprolactone polyethylene glycol copolymer microsphere, preparation method therefor, and use thereof
WO2023083258A1
